Clinical Trial Update: Lidocaine 5% Plasters (Versatis® 5%) in Pediatric Neuropathic Pains and Vasoocclusive Sickle Cell Crisis Pains [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of lidocaine 5% plaster (Versatis) in pediatric neuropathic pain and vaso-occlusive pain in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Sickle Cell Disease

Drugs mentioned

• Versatis 5% lidocaine plaster (lidocaine)

Snippet

Sponsor: Centre Leon Berard | Conditions: Neuropathic Pains, Vasoocclusive Sickle Cell Crises Pains | Phase 2 | Status: COMPLETED